Labile Plasma Iron predicts for survival in patients undergoing allogeneic-stem cell transplantation – results from the prospective multicenter German-Austrian ALLIVE trial. May 7, 2017August 13, 2017 liorco70 http://d22fjzb79sfamb.cloudfront.net/MDS2017/sat/1030%20-%201230/Sat%201130.mp4 M. Wermke (Germany)